Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circulating MicroRNAs in SLE Pathogenesis
NCT02756546Phase 2Completed
- Sponsor
- Cairo University
- Start
- Sep 2014
- Primary completion
- Sep 2015
01
Overview
Phase 2, open-label trial (2 arms), sponsored by Cairo University. Primary endpoint: MicroRNAs expression level at 3 months. Started Sep 2014; status: completed.
Beyond the preview
Go deeper on NCT02756546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02756546.